DCM
AMRX icon

Dupont Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Dupont Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-44,756
Closed -$142K – 1532
2022
Q2 		$142K Hold
44,756
– – 0.01% 1088
2022
Q1 		$187K Buy
+44,756
New +$198K 0.01% 1073
2020
Q1 		– Sell
-143,847
Closed -$693K – 1271
2019
Q4 		$693K Buy
143,847
+38,228
+36% +$133K 0.02% 693
2019
Q3 		$306K Buy
+105,619
New +$369K 0.01% 983

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dupont Capital Management's AMRX Position: Q3 2022 in Review

Dupont Capital Management sold out of Amneal Pharmaceuticals (AMRX) in Q3 2022, closing a stake of 44,756 shares — an estimated $142K sold.

Dupont Capital Management first reported a position in AMRX in Q3 2019 and held it in 4 quarters. The position peaked at $693K in Q4 2019. 154 funds tracked by Wall St. Rank hold AMRX as of Q3 2022.

  • Dupont Capital Management reported no remaining Amneal Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Dupont Capital Management sold 44,756 Amneal Pharmaceuticals shares in Q3 2022, an estimated $142K.
  • Dupont Capital Management first reported a position in Amneal Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • Dupont Capital Management's Amneal Pharmaceuticals position peaked at $693K in Q4 2019.
  • 154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2022.

Based on Dupont Capital Management's 13F filing for Q3 2022, filed 31 Oct 2022.